Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Sekundarni maligni tumor debelega črevesja po zdravljenju raka v otroštvu
Authors:ID Zadravec-Zaletel, Lorna (Author)
ID Vujasinović, Miroslav (Author)
ID Boc, Marko (Author)
ID Jereb, Berta (Author)
Files:.pdf PDF - Presentation file, download (358,67 KB)
MD5: 44BAEDAE6A44622A172FA61869F5D1DF
PID: 20.500.12556/dirros/cfc0b437-9ec9-4638-b080-a710287f2ec4
 
Language:Slovenian
Typology:1.09 - Published Professional Conference Contribution
Organization:Logo OI - Institute of Oncology
Abstract:Tveganje za nastanek sekundarnega raka debelega črevesja je pri bolnikih, ki so se zdravili zaradi raka v otroštvu, večje od tistega v splošni populaciji in strmo narašča s časom opazovanja ter s povečano dozo obsevanja v predelu trebuha. Pri bolniku, ki je bil v starosti 12 let uspešno zdravljen zaradi Hodgkinove bolezni s kemoterapijo in obsevanjem prizadetih regij, vključno paraaortnih bezgavk, je bila 27 let po zdravljenju ugotovljena mikrocitna hipohromna anemija. Sum, da gre za gastrointestinalno krvavitev z enkratno preiskavo blata, ni bil potrjen. Pol leta kasneje je bil ugotovljen metastatski adenokarcinom debelega črevesja. Zdravljen je bil operativno, s sistemskim zdravljenjem in paliativnim obsevanjem spinalnih ter možganskih metastaz. Leto in pol po začetku zdravljenja sekundarnega tumorja je bolnik v starosti 40 let umrl. Pri bolnikih, zdravljenih zaradi raka v otroštvu, so pozne posledice številne. Sekundarni maligni tumorji so drugi najpogostejši vzrok smrti, takoj za recidivom bolezni. Zato je zelo pomembno, da jih pravočasno odkrijemo in ustrezno zdravimo. Od leta 2014 je za bolnike, ki so prejeli 30 Gy ali več na predel trebuha, v mednarodnih smernicah priporočeno spremljanje s kolonoskopijo. Enkratna preiskava blata na kri in UZ trebuha nista zanesljivi metodi za odkrivanje raka debelega črevesja.
Keywords:kasne posledice raka, rak pri otrocih, rak, otroci
Publication status:Published
Publication version:Version of Record
Year of publishing:2014
Number of pages:str. 69-71, 77
Numbering:Letn. 18, št. 1
PID:20.500.12556/DiRROS-8668 New window
UDC:616-006
ISSN on article:1408-1741
URN:URN:NBN:SI:doc-8AYJHBK7
COBISS.SI-ID:1810555 New window
Copyright:by Authors
Publication date in DiRROS:31.08.2018
Views:3880
Downloads:959
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Šola: tumorji prebavil II, Ljubljana, 15. 11. 2013
Publisher:Onkološki inštitut
COBISS.SI-ID:1807227 New window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:31.08.2018

Secondary language

Language:English
Title:[Secondary malignant tumour of the colon after childhood cancer treatment - a case report]
Abstract:The risk of developing secondary colon cancer is larger in patients treated for childhood cancer than in the general population, and it is rapidly increasing with observation time and increased radiation dose to the abdominal area. A patient, who was successfully treated for Hodgkin’s disease at the age of 12 with chemotherapy and radiation of the affected regions, including para-aortic lymph nodes, was diagnosed with microcytic hypochromic anaemia 27 years after treatment. A suspicion that this is gastrointestinal haemorrhage was not confirmed by a single-stool examination. Half a year later, the patient was found with metastatic adenocarcinoma of the colon and was treated operatively with systemic treatment and palliative radiation of spinal and brain metastases. A year and a half after the start of treatment of secondary tumour, the patient died at the age of 40 years. Patients treated for childhood cancer experience several late consequences. Secondary malignant tumours are the second most common cause of death, right after disease recurrence. Therefore, timely detection and appropriate treatment are of utmost importance. Since 2014, the international guidelines recommend that patients receiving 30 Gy or more to the abdominal region are monitored by colonoscopy. A single-stool examination for occult blood and US of the abdomen are not reliable methods for detecting colon cancer.


Archive

niGradiv

Back